Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

Diagnosing Acidosis and Alkalosis

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and HCO3− values are examined to...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impaired task-dependent cerebral cortex oxygenation in Glut1 deficiency.

Frontiers in neuroscience·2026

Same author

fNIRS insights into brain biomarkers of maple syrup urine disease (MSUD).

Molecular genetics and metabolism·2026

Same author

Functional profiling of 2,193 ASS1 missense variants: Insights into variant pathogenicity and epistatic interactions in citrullinemia type I.

PLoS genetics·2026

Same author

Re: Pegvaliase Treatment for Adolescents With Phenylketonuria: A Multi-Site Study.

JIMD reports·2026

Same author

Pediatric liver transplantation for metabolic diseases: a single-center experience.

World journal of pediatrics : WJP·2026

Same author

Resources and care structures for management of urea cycle disorders in Japan and the United States: A system-level comparison.

Molecular genetics and metabolism·2026

Search research articles

Related Experiment Video

Updated: May 28, 2026

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

Published on: March 8, 2024

Acute management of propionic acidemia.

Kimberly A Chapman¹, Andrea Gropman, Erin MacLeod

¹Children's National Medical Center, Washington, DC 20010, USA. kchapman@childrensnational.org

Molecular Genetics and Metabolism

|October 18, 2011

Summary

Propionic acidemia (PA) is a metabolic disorder causing severe illness during catabolism. This study outlines critical recommendations for the acute management of PA patients to prevent death.

More Related Videos

Quantification of Coenzyme A in Cells and Tissues

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

Related Experiment Videos

Last Updated: May 28, 2026

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid

Published on: March 8, 2024

Quantification of Coenzyme A in Cells and Tissues

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

Area of Science:

Biochemistry
Genetics
Pediatrics

Background:

Propionic acidemia (PA) is an organic acidemia, a disorder of organic metabolism.
Metabolic decompensation in PA patients occurs during increased metabolic demand and catabolism, leading to severe symptoms like lethargy, vomiting, coma, and potentially death.
Prompt and appropriate treatment is crucial for preventing mortality and morbidity.

Purpose of the Study:

To develop evidence-based recommendations for the acute management of individuals with propionic acidemia.
To provide guidance applicable to both newly diagnosed neonates and known patients experiencing metabolic decompensation.
To outline strategies for initial treatment, evaluation, and transport to specialized metabolic centers.

Main Methods:

A consensus meeting was held with clinicians, scientists, and parent representatives.
Recommendations were designed based on expert consensus and clinical experience.
The focus was on acute management strategies for propionic acidemia.

Main Results:

The manuscript presents recommendations for initial treatment and evaluation of propionic acidemia.
It addresses critical issues concerning patient transport to a metabolic center.
Strategies for accelerating management and preparing for discharge are detailed.

Conclusions:

Effective acute management is vital for preventing mortality and morbidity in propionic acidemia.
The developed recommendations aim to standardize and improve the care of affected individuals.
These guidelines are applicable across different patient populations and clinical scenarios.